Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.013 | 0.8 |